BEFORE THE DEPARTMENT OF PUBLIC

HEALTH AND HUMAN SERVICES OF THE

STATE OF MONTANA

 

In the matter of the adoption of New Rules I through III and the amendment of ARM 37.86.4401 pertaining to collaborative practice drug therapy management

) ) ) ) )

NOTICE OF ADOPTION AND AMENDMENT

 

TO: All Concerned Persons

 

1. On April 28, 2017, the Department of Public Health and Human Services published MAR Notice No. 37-792 pertaining to the public hearing on the proposed adoption and amendment of the above-stated rules at page 475 of the 2017 Montana Administrative Register, Issue Number 8.

 

2. The department has adopted the following rules as proposed: New Rule I (37.86.901) and III (37.86.905).

 

3. The department has amended the following rule as proposed: ARM 37.86.4401.

 

4. The department has adopted the following rule as proposed, but with the following changes from the original proposal, new matter underlined, deleted matter interlined:

 

NEW RULE II (37.86.902) COLLABORATIVE PRACTICE DRUG THERAPY MANAGEMENT - REQUIREMENTS AND ELIGIBILITY (1) remains as proposed.

(2) A clinical pharmacist practitioner who provides collaborative practice drug therapy management must:

(a) and (b) remain as proposed.

(c) provide care through employment or contract with within the physical practice of a medical practitioner or facility.

(3) remains as proposed.

 

AUTH:  53-2-201, 53-6-113, MCA

IMP:  53-2-201, 53-6-101 53-6-113, MCA

 

5. The department has thoroughly considered the comments and testimony received. A summary of the comments received and the department's responses are as follows:

 

COMMENT #1: Several commenters presented thoughts of affirmation and support that establishing the Collaborative Practice Drug Therapy Management program will provide better access and improved care to the Medicaid population.

 

RESPONSE #1: The department appreciates the comments submitted.

 

COMMENT #2: A commenter expressed concern that the service should be integrated within a medical practitioner's office and as proposed there is potential that this service could be provided in a retail pharmacy setting if all other requirements were met.

 

RESPONSE #2: The department concurs with this comment and has updated the proposed language to better articulate the intent of the program. Collaborative Practice Drug Therapy Management is intended to be provided within a clinical setting of a medical practitioner's office or facility.

 

            6. These rule adoptions and amendments are effective July 1, 2017.

 

 

 

/s/ Brenda K. Elias                                       /s/ Sheila Hogan                                         

Brenda K. Elias, Attorney                           Sheila Hogan, Director

Rule Reviewer                                            Public Health and Human Services

           

Certified to the Secretary of State June 12, 2017.